Case Report: Successful telitacicept treatment for IgA nephropathy with stage 4 chronic kidney disease and acute renal failure

By
Fang Zeng
Fei Tan
Dehui Liu
Fang Wang
July 14, 2026

Frontiers In Immunology

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

#1

Ganzhou Hospital-Nanfang Hospital

Ganzhou, Jiangxi
Key Differentiators
- Nephrology
#2

Henan Provincial People’s Hospital

Zhengzhou, Henan
Key Differentiators
- Nephrology
#3

Far Eastern Memorial Hospital

New Taipei, Taiwan
Key Differentiators
- Nephrology
#4

Linkou Chang Gung Memorial Hospital

Taoyuan, Taiwan
Key Differentiators
- Nephrology
#5

University Heart and Vascular Center Hamburg

Hamburg, Germany
Key Differentiators
- Nephrology

Original Source(s)

Frontiers In Immunology

Case Report: Successful telitacicept treatment for IgA nephropathy with stage 4 chronic kidney disease and acute renal failure

by Fang Zeng, Fei Tan, Dehui Liu, Fang Wang
July 14, 2026

Related Content

Conexiant

CGM Linked to More Time in Range

In a randomized crossover trial of insulin-treated patients receiving hemodialysis, real-time continuous glucose monitoring did not improve the primary hypoglycemia outcome but increased time in range and reduced time above range vs capillary testing.

by Andrea Surnit
July 14, 2026
4 min

Conexiant

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.